Physician profile
Robin Simon-Mark
NPI 1053359919
$295.14
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.51 · 2020: $60.95 · 2023: $64.73 · 2024: $76.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $81.06 | 2019-2024 | Gamma |
| Bioventus LLC | $56.50 | 2023-2024 | Supartz Fx Sodium Hyaluronate, Supartz Fx Sodium Hyaluronate |
| Pacira Therapeutics, INC. | $40.16 | 2020 | |
| Smith+Nephew, INC. | $39.73 | 2023 | Evos |
| Fidia Pharma USA INC. | $24.74 | 2019 | |
| Djo, LLC | $20.79 | 2020 | |
| Orthofix Medical, INC. | $17.65 | 2024 | Physio-Stim |
| Cashflow Solutions, LLC | $14.51 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Simon-Mark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.